SureTrader Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

Add NVAX Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 7/20/2016 3:12:34 PM - Followers: 135 - Board type: Free - Posts Today: 0


Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.


President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.



Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NVAX News: Biotechnology Equities Under the Scanner - Exelixis, Novavax, Celgene, and Ariad Pharma 07/07/2016 08:00:00 AM
NVAX News: Novavax Recognized by Washington Post as Top Workplace 06/17/2016 08:30:35 AM
NVAX News: Novavax Recognized by Washington Post as Top Workplace 06/17/2016 08:30:00 AM
NVAX News: Current Report Filing (8-k) 06/10/2016 05:24:18 PM
NVAX News: Statement of Changes in Beneficial Ownership (4) 06/07/2016 04:15:36 PM
#2264   NVAX DAY TREND1 07/20/16 03:12:34 PM
#2263   NVAX bullish 7.52 stocktrademan 07/07/16 10:19:26 AM
#2262   Nice rebound today after Brexit. girlfriend 06/28/16 12:32:47 PM
#2261   News now ClearlyStocks 06/02/16 04:03:08 PM
#2260   Have 5350 shares at 4.53 still holding any don estaban 05/31/16 06:14:55 PM
#2259   Hope your still in binks 05/31/16 06:10:31 PM
#2258   Congress tells Obama he can get OFF at AVALANCHE06 04/13/16 02:45:45 PM
#2257   Quite possibly. LongRun8 04/12/16 03:30:11 PM
#2256   $1.9Billion for Zika virus asked from Congress by north40000 04/11/16 08:39:09 PM
#2255   $NVAX is Great...Think BIG! MRatt 04/09/16 12:12:27 AM
#2254   Stupid stock henrytrean 04/07/16 02:19:14 PM
#2253   Nice day today ! don estaban 04/06/16 08:16:56 PM
#2252   I believe that volume at close was options expiring. bra1loga 03/21/16 09:15:27 AM
#2251   I picked up 12k shares around 4.70 looking don estaban 03/19/16 12:33:18 PM
#2250   Still here... $NVAX is the Man! MRatt 03/19/16 12:20:28 PM
#2249   Hmmm. That's a lot of volume. LongRun8 03/18/16 06:19:24 PM
#2248   3.5 million buy at 5.07 ?? don estaban 03/18/16 04:21:22 PM
#2247   Yup, still here. Just waiting till Q3. LongRun8 03/15/16 04:23:08 PM
#2246   Anybody here? don estaban 03/14/16 11:52:10 PM
#2245   Movers and Shakers: The Week so Far in nyctraydr 01/26/16 01:57:28 PM
#2244   I have thought about the fact that they LongRun8 01/26/16 09:12:56 AM
#2243   They have plenty of cash, could the funds Tate 01/26/16 08:51:06 AM
#2242   Correct. Must meet the exception. What LongRun8 01/26/16 07:12:22 AM
#2241   That has to do with sale of shares BigBake1 01/26/16 05:57:29 AM
#2240   Update tonight $300M @ NVAX Investor100 01/25/16 10:34:50 PM
#2239   $300 million, up from $200 million offer Novavax Prices LongRun8 01/25/16 09:33:22 PM
#2238   Missed that part... but I would surmise that AVALANCHE06 01/25/16 08:44:20 PM
#2237   Also, only outside the US... "The offer and sale LongRun8 01/25/16 05:26:56 PM
#2236   Says will be sold only to Qualified Institutions.....maybe AVALANCHE06 01/25/16 04:58:29 PM
#2235   Novavax Announces Proposed Offering of $200 Million of Investor100 01/25/16 02:58:30 PM
#2234   CEO @ Mad Money Investor100 01/16/16 12:04:33 PM
#2233   Pure craziness today! I think patient investors LongRun8 01/14/16 10:51:10 PM
#2232   NVAX has the potential to be bought out stockwinner 11/24/15 03:19:37 PM
#2231   153 "contacts" under observation, Reuters reported. north40000 11/23/15 10:43:32 PM
#2230   Geez, just when you thought Ebola was gone. LongRun8 11/23/15 10:39:26 PM
#2229   3 new Ebola cases emerge in Liberia, Reuters north40000 11/23/15 10:22:10 PM
#2228   No new insight. Everything is pretty much LongRun8 11/23/15 10:22:18 AM
#2227   Any new insight here? basssque 11/22/15 11:29:09 AM
#2226   NVAX is enrolling for RSV Ph 3. nypete 11/03/15 06:19:49 PM
#2225   Biotech is on a fire sale. nypete 09/29/15 03:40:33 PM
#2224   It wasn't the reason. It was the excuse. Juice Newton 09/29/15 03:12:19 PM
#2223   Another bogus tweet apparently the reason for initial north40000 09/29/15 09:53:37 AM
#2222 Stock price down despite this second PR. north40000 09/29/15 09:37:00 AM
#2221   Novavax Announces Grant of Up to $89 Million LongRun8 09/29/15 09:04:05 AM
#2220   Confidential Treatment Order - CTO sarshee 09/27/15 02:25:09 AM
#2219   What the heck is happening here? Does anyone sarshee 09/27/15 02:18:51 AM
#2218   If there was a secondary coming, Stan would underdog150 09/25/15 04:32:29 PM
#2217   There may be a secondary but I doubt Billcoln 09/23/15 11:41:19 PM
#2216   Has anyone looked at the Jan 2018 options owen3838 09/16/15 10:49:47 PM
#2215   We'll see if there's any info that comes VisionsofSugarPlums 09/08/15 01:25:13 PM